Trump, who met the CEOs of major US pharmaceutical companies in a ... And that's a bad news for Indian companies at time when the drug makers ...
Read more: Trump calls for drug price-cuts, make in US & ease FDA approvals
Tuesday, January 31, 2017
Pharma Reviews: Indian Pharma not too worried over Trump talk
New Delhi: Indian drug makers, who earn almost 50% of their revenues from the American market, are keeping their fingers crossed after US ...
Read more: Indian Pharma not too worried over Trump talk
Read more: Indian Pharma not too worried over Trump talk
Pharma Reviews: Indian pharma firms not worried over Trump's drug talk
Though Indian pharmaceutical industry, see Trump's bashing of American Big Pharma industry as an opportunity, it is also cautious due to possibility ...
Read more: Indian pharma firms not worried over Trump's drug talk
Read more: Indian pharma firms not worried over Trump's drug talk
Pharma Reviews: Trump's policy can affect India's pharmaceutical companies
Trump asked big pharmaceutical companies to change their pricing policies. He said, "We have to get lower prices, we have to get even better ...
Read more: Trump's policy can affect India's pharmaceutical companies
Read more: Trump's policy can affect India's pharmaceutical companies
Pharma Reviews: Buy American: Trump's call to pharma firms to move back to US
Washington: Foreshadowing "Buy American" moves that could affect the largest market for Indian pharmaceutical companies, US President Donald ...
Read more: Buy American: Trump's call to pharma firms to move back to US
Read more: Buy American: Trump's call to pharma firms to move back to US
Pharma Reviews: Trump's call to pharma firms to move back to US could hit Indian exporters
WASHINGTON: Foreshadowing "Buy American" moves that could affect the largest market for Indian pharmaceutical companies, US President Donald ...
Read more: Trump's call to pharma firms to move back to US could hit Indian exporters
Read more: Trump's call to pharma firms to move back to US could hit Indian exporters
Pharma Reviews: Indian pharma industry fears tougher US stance on IP
The Indian pharma industry fears a tougher US government stance on intellectual property rules after US President Donald Trump asserted that ...
Read more: Indian pharma industry fears tougher US stance on IP
Read more: Indian pharma industry fears tougher US stance on IP
Pharma Reviews: Pharmaceutical stocks decline on Trump remarks
Analysts said the Indian generic pharma industry has been addressing the need for affordable pharmaceuticals of the US patients and enabled the US ...
Read more: Pharmaceutical stocks decline on Trump remarks
Read more: Pharmaceutical stocks decline on Trump remarks
Pharma Reviews: After IT, Trump targets pharma; says will name US FDA chief soon
In what could be a blow to the Indian pharma industry, US President Donald Trump today said that other countries have been taking advantage of the ...
Read more: After IT, Trump targets pharma; says will name US FDA chief soon
Read more: After IT, Trump targets pharma; says will name US FDA chief soon
Monday, January 30, 2017
Pharma Reviews: Union govt to come out with a scheme to support new pharma and medical device parks
This sector has been gaining significant attention and this event India Pharma and Medical Devices 2017 is expected to garner investments to spur ...
Read more: Union govt to come out with a scheme to support new pharma and medical device parks
Read more: Union govt to come out with a scheme to support new pharma and medical device parks
US FDA News: Halo One Thin-Walled Guiding Sheath by Bard Peripheral Vascular Inc.: Class I Recall - Sheath Separation, Kinking, or Tip Damage
The affected product may cause serious adverse health consequences such as internal tears and perforation to arteries or veins, excessive bleeding, and death.
Read more: Halo One Thin-Walled Guiding Sheath by Bard Peripheral Vascular Inc.: Class I Recall - Sheath Separation, Kinking, or Tip Damage
Read more: Halo One Thin-Walled Guiding Sheath by Bard Peripheral Vascular Inc.: Class I Recall - Sheath Separation, Kinking, or Tip Damage
Pharma Reviews: Cardiac stent notification by mid-Feb, mandatory UCPMP on the cards, US President Trump's ...
To another query on US President Trump's policy impact on India, pharma, Kumar said that there ... I also don't think, there will not be any problem for the Indian pharmaceutical, biotech and information technology sector,” he said.
Read more: Cardiac stent notification by mid-Feb, mandatory UCPMP on the cards, US President Trump's ...
Read more: Cardiac stent notification by mid-Feb, mandatory UCPMP on the cards, US President Trump's ...
Pharma Reviews: India's IT, Auto, Pharma sectors may face brunt of Trump's border tax
Analysts expects that such would not harm India's economy as it is ... “We expect another muted quarter for the pharma sector led by weakness in US ...
Read more: India's IT, Auto, Pharma sectors may face brunt of Trump's border tax
Read more: India's IT, Auto, Pharma sectors may face brunt of Trump's border tax
Pharma Reviews: Biocon aims for the highest quality at the lowest cost: Kiran Mazumdar Shaw
While the rest of the Indian pharma industry followed business models led by small molecules, you decided to focus on technology intensive large ...
Read more: Biocon aims for the highest quality at the lowest cost: Kiran Mazumdar Shaw
Read more: Biocon aims for the highest quality at the lowest cost: Kiran Mazumdar Shaw
Sunday, January 29, 2017
Pharma Reviews: Donald Trump's policy not to hit Indian IT, pharma firms: Ananth Kumar
Union Minister for Chemicals and Fertilizers HN Ananth Kumar BENGALURU: Indian IT, Biotech and pharma industries will not be impacted due to ...
Read more: Donald Trump's policy not to hit Indian IT, pharma firms: Ananth Kumar
Read more: Donald Trump's policy not to hit Indian IT, pharma firms: Ananth Kumar
Pharma Reviews: We can fix unavailability of medicines: Pradyumn Singh
India is a prescription-led market and distribution in the Indian pharmaceutical sector is very fragmented. There are close to 10 lakh retail shops and ...
Read more: We can fix unavailability of medicines: Pradyumn Singh
Read more: We can fix unavailability of medicines: Pradyumn Singh
Pharma Reviews: IDMA urges Centre to offer capital-linked budget incentives for pharma biz
Ahmedabad: With the Union budget set to be presented next week, Indian Drug Manufacturers Association (IDMA) has urged the Centre to make a ...
Read more: IDMA urges Centre to offer capital-linked budget incentives for pharma biz
Read more: IDMA urges Centre to offer capital-linked budget incentives for pharma biz
Pharma Reviews: Trump's Policy Not to Hit Indian IT, Pharma Firms: Union Minister
Bengaluru: Indian IT, Biotech and pharma industries will not be impacted due to Donald Trump's policies as the US is expected to continue "the ...
Read more: Trump's Policy Not to Hit Indian IT, Pharma Firms: Union Minister
Read more: Trump's Policy Not to Hit Indian IT, Pharma Firms: Union Minister
Pharma Reviews: HC allows Indian firm to export drug in which Bayer has patent
NEW DELHI: In a setback to German pharma major 'Bayer', Delhi High Court has suspended its order restraining an Indian drug company from ...
Read more: HC allows Indian firm to export drug in which Bayer has patent
Read more: HC allows Indian firm to export drug in which Bayer has patent
Saturday, January 28, 2017
Pharma Reviews: 'Notification on stent pricing in 15 days'
The Department of Pharmaceuticals, Ministry of Chemicals and Fertilisers, along with Federation of Indian Chambers of Commerce and Industry will ...
Read more: 'Notification on stent pricing in 15 days'
Read more: 'Notification on stent pricing in 15 days'
Pharma Reviews: Trump's policy not to hit Indian IT, pharma firms: Union Minister
Indian IT, Biotech and pharma industries will not be impacted due to Donald Trump's policies as the United States is expected to continue “the ...
Read more: Trump's policy not to hit Indian IT, pharma firms: Union Minister
Read more: Trump's policy not to hit Indian IT, pharma firms: Union Minister
Pharma Reviews: India Pharma for responsible Healthcare
The Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers, along with Federation of Indian Chambers of Commerce & Industry ...
Read more: India Pharma for responsible Healthcare
Read more: India Pharma for responsible Healthcare
Friday, January 27, 2017
US FDA News: Certain Homeopathic Teething Products: FDA Warning- Confirmed Elevated Levels of Belladonna
Homeopathic teething products containing belladonna pose an unnecessary risk to infants and children. Posted 01/27/2017
Read more: Certain Homeopathic Teething Products: FDA Warning- Confirmed Elevated Levels of Belladonna
Read more: Certain Homeopathic Teething Products: FDA Warning- Confirmed Elevated Levels of Belladonna
US FDA News: NucliSENS easyMAG Magnetic Silica and NucliSENS Magnetic Extraction Reagents by bioMerieux: Recall - Potential Inaccurate Test Results
Risk of false negative results, invalid results, or under-quantification for clinical laboratory tests. This error may result in inappropriate treatment or delay in treatment.
Read more: NucliSENS easyMAG Magnetic Silica and NucliSENS Magnetic Extraction Reagents by bioMerieux: Recall - Potential Inaccurate Test Results
Read more: NucliSENS easyMAG Magnetic Silica and NucliSENS Magnetic Extraction Reagents by bioMerieux: Recall - Potential Inaccurate Test Results
US FDA News: FDA confirms elevated levels of belladonna in certain homeopathic teething products
The U.S. Food and Drug Administration announced today that its laboratory analysis found inconsistent amounts of belladonna, a toxic substance, in certain homeopathic teething tablets, sometimes far exceeding the amount claimed on the label. The agency is warning consumers that homeopathic teething tablets containing belladonna pose an unnecessary risk to infants and children and urges consumers not to use these products.
Read more: FDA confirms elevated levels of belladonna in certain homeopathic teething products
Read more: FDA confirms elevated levels of belladonna in certain homeopathic teething products
Pharma Reviews: Pharma has six pain points; Budget 2017 should address them to boost growth
Phasing out of weighted deductions: According to figures, the Indian pharmaceutical sector has the potential to grow exponentially to the size of $300 ...
Read more: Pharma has six pain points; Budget 2017 should address them to boost growth
Read more: Pharma has six pain points; Budget 2017 should address them to boost growth
Pharma Reviews: 'Donald Trump's push for lower drug prices to benefit Indian pharma'
NEW DELHI: Indian pharmaceutical sector is likely to gain, rather than being impacted, as the new US President Donald Trump aims to reduce drug ...
Read more: 'Donald Trump's push for lower drug prices to benefit Indian pharma'
Read more: 'Donald Trump's push for lower drug prices to benefit Indian pharma'
Pharma Reviews: Pharma industry wants budget to offer more clarity in terms of...
The industry players want the government to provide a road map towards ... The Indian Drug Manufacturers Association (IDMA), a body comprising ...
Read more: Pharma industry wants budget to offer more clarity in terms of...
Read more: Pharma industry wants budget to offer more clarity in terms of...
Thursday, January 26, 2017
Pharma Reviews: Pharma industry hopes for faster licences
Hyderabad: The Indian pharma industry is pegged around Rs 2 lakh crore and of this the domestic industry is pegged at Rs 1 lakh crore and exports ...
Read more: Pharma industry hopes for faster licences
Read more: Pharma industry hopes for faster licences
Pharma Reviews: IPA to organise Technical Conference in Ahmedabad on Jan-28 to improve practice & reporting of ...
In order to help participants improve their practice and reporting of quality metrics to US FDA, the Indian Pharmaceutical Association (IPA) Industrial ...
Read more: IPA to organise Technical Conference in Ahmedabad on Jan-28 to improve practice & reporting of ...
Read more: IPA to organise Technical Conference in Ahmedabad on Jan-28 to improve practice & reporting of ...
Pharma Reviews: IDMA urges central govt to eliminate bottlenecks in API sector, incentivise exports
Against the backdrop of issues the Indian API industry has been facing and ... to present good commercial opportunities for Indian pharma industry.
Read more: IDMA urges central govt to eliminate bottlenecks in API sector, incentivise exports
Read more: IDMA urges central govt to eliminate bottlenecks in API sector, incentivise exports
Pharma Reviews: GST on healthcare will make medicare unaffordable, says ASSOCHAM-TechSci study
New Delhi, Jan 25 : The healthcare sector catering to the unmet health ... The Indian pharma industry, with an estimated turnover at USD 36.7 billion in ...
Read more: GST on healthcare will make medicare unaffordable, says ASSOCHAM-TechSci study
Read more: GST on healthcare will make medicare unaffordable, says ASSOCHAM-TechSci study
Wednesday, January 25, 2017
Pharma Reviews: 'Trump's push for lower drug prices to benefit Indian pharma sector'
Indian pharmaceutical sector is likely to gain, rather than being impacted, as the new US President Donald Trump aims to reduce drug prices since the ...
Read more: 'Trump's push for lower drug prices to benefit Indian pharma sector'
Read more: 'Trump's push for lower drug prices to benefit Indian pharma sector'
US FDA News: Vancomycin Hydrochloride for Injection, USP by Hospira: Recall - Particulate Matter in Vial
Injected particulate may result in local swelling, irritation of blood vessels or tissue, blockage of blood vessels and/or low-level allergic response to the particulate.
Read more: Vancomycin Hydrochloride for Injection, USP by Hospira: Recall - Particulate Matter in Vial
Read more: Vancomycin Hydrochloride for Injection, USP by Hospira: Recall - Particulate Matter in Vial
Pharma Reviews: Healthcare Budget 2017: Government should raise tax exemption on preventive health check-up ...
New Delhi, January 25: The healthcare sector must be kept out of the ... The Indian pharma industry, with an estimated turnover at USD 36.7 billion in ...
Read more: Healthcare Budget 2017: Government should raise tax exemption on preventive health check-up ...
Read more: Healthcare Budget 2017: Government should raise tax exemption on preventive health check-up ...
Pharma Reviews: Indian pharma likely to report tepid earnings growth for Q3 FY17
The Indian pharmaceutical sector has seen a significant share of market value erode over the last couple of years owing to multiple challenges, most ...
Read more: Indian pharma likely to report tepid earnings growth for Q3 FY17
Read more: Indian pharma likely to report tepid earnings growth for Q3 FY17
Pharma Reviews: Keep healthcare out of GST purview: Assocham
New Delhi, Jan 25 (PTI) Healthcare sector should be kept outside the ... The Indian pharma industry, with an estimated turnover of USD 36.7 billion in ...
Read more: Keep healthcare out of GST purview: Assocham
Read more: Keep healthcare out of GST purview: Assocham
Pharma Reviews: Pharma industry seeks more tax clarity & incentives for R&D purposes
With a view to introduce the balance in the rate of excise duties, Indian Drug Manufacturers Association (IDMA) said that all excisable goods used for ...
Read more: Pharma industry seeks more tax clarity & incentives for R&D purposes
Read more: Pharma industry seeks more tax clarity & incentives for R&D purposes
Pharma Reviews: Ethical minefield: Pharma industry's gifts to doctors can be tax deductable, rules tribunal
More relevantly, the Medical Council of India regulations pertain to doctors and not to pharmaceutical companies and allied health sector industries.
Read more: Ethical minefield: Pharma industry's gifts to doctors can be tax deductable, rules tribunal
Read more: Ethical minefield: Pharma industry's gifts to doctors can be tax deductable, rules tribunal
Pharma Reviews: GST on healthcare will make medicare unaffordable, says ASSOCHAM-TechSci study
So, there is a strong case for the sector to be spared the GST," said ... The Indian pharma industry, with an estimated turnover at USD 36.7 billion in ...
Read more: GST on healthcare will make medicare unaffordable, says ASSOCHAM-TechSci study
Read more: GST on healthcare will make medicare unaffordable, says ASSOCHAM-TechSci study
Tuesday, January 24, 2017
Pharma Reviews: Budget 2017: Weighted deductions for incurring pharma R&D should continue
The pharmaceutical sector has been one of the key sectors in the shaping up of the Indian economy and it will continue playing a major role in its ...
Read more: Budget 2017: Weighted deductions for incurring pharma R&D should continue
Read more: Budget 2017: Weighted deductions for incurring pharma R&D should continue
Pharma Reviews: Why India's generic-drug industry has a long way to go to gain US FDA's trust
India supplies 40% of the generic medications consumed in the US, where copycats account for more than 8 in 10 prescriptions. Photo: Bloomberg.
Read more: Why India's generic-drug industry has a long way to go to gain US FDA's trust
Read more: Why India's generic-drug industry has a long way to go to gain US FDA's trust
Monday, January 23, 2017
Pharma Reviews: Pharma industry wants Budget to offer tax clarity
The Indian Drug Manufacturers Association (IDMA), a body comprising mostly home-grown pharma firms, said all excisable goods used for R&D ...
Read more: Pharma industry wants Budget to offer tax clarity
Read more: Pharma industry wants Budget to offer tax clarity
Pharma Reviews: Japanese lender key financier of pharma M&As
Over the past two-odd years, MUFG has led almost all major outbound merger & acquisition (M&A) financing for Indian pharma companies.
Read more: Japanese lender key financier of pharma M&As
Read more: Japanese lender key financier of pharma M&As
Pharma Reviews: Union Budget 2017: An opportunity to drive innovation and rapid growth in the pharma sector
Budget 2017: The Indian pharmaceutical industry is on the threshold of becoming a major global market by 2020 with revenues close to Rs 1,652 ...
Read more: Union Budget 2017: An opportunity to drive innovation and rapid growth in the pharma sector
Read more: Union Budget 2017: An opportunity to drive innovation and rapid growth in the pharma sector
Pharma Reviews: Need for promotion of API industry and SMEs to boost pharma industry: IDMA
These were some of the thoughts deliberated as part of the 55th Indian Drug Manufacturers Association (IDMA) annual celebration under the theme ...
Read more: Need for promotion of API industry and SMEs to boost pharma industry: IDMA
Read more: Need for promotion of API industry and SMEs to boost pharma industry: IDMA
Pharma Reviews: Trump's 'America First' policy to maul Indian IT, pharma sectors: Nasscom
The new US administration under President Donald Trump has vowed to follow an isolationist trade policy that is both against global trade norms set ...
Read more: Trump's 'America First' policy to maul Indian IT, pharma sectors: Nasscom
Read more: Trump's 'America First' policy to maul Indian IT, pharma sectors: Nasscom
Pharma Reviews: Trump intervention in pharma may affect Indian suppliers: PwC
Shetty said talk of a border tax on imports could lead to a higher cost for Indian pharma companies in terms of exports. He added that even though ...
Read more: Trump intervention in pharma may affect Indian suppliers: PwC
Read more: Trump intervention in pharma may affect Indian suppliers: PwC
Sunday, January 22, 2017
Pharma Reviews: Over Rs 2500 crore saved in pharma sector post control of ceiling price of 853 formulations
The turnover of the Indian pharmaceutical industry was estimated at Rs 2,04,627.1 crore in FY 2015-16. The Indian pharmaceutical industry has ...
Read more: Over Rs 2500 crore saved in pharma sector post control of ceiling price of 853 formulations
Read more: Over Rs 2500 crore saved in pharma sector post control of ceiling price of 853 formulations
Pharma Reviews: Illegal pharma drugs business hitting Indian markets
This unregulated trade has taken a firm root in India as a supplier and had ... In 2016, more than 500 kg of tablets (pharmaceutical drugs) have been ...
Read more: Illegal pharma drugs business hitting Indian markets
Read more: Illegal pharma drugs business hitting Indian markets
Pharma Reviews: Indian pharma pads up to fight Republican border tax
... for Indian pharmaceutical companies. Republican senators propose to slap a BAT as a tax reform. Under the proposal, US companies would not be ...
Read more: Indian pharma pads up to fight Republican border tax
Read more: Indian pharma pads up to fight Republican border tax
Saturday, January 21, 2017
Pharma Reviews: IT, pharma in search of Trump card
New Delhi, Jan. 21: Indian pharmaceutical majors and technology giants are in a "wait-and-watch" mode over newly-elected US President Donald ...
Read more: IT, pharma in search of Trump card
Read more: IT, pharma in search of Trump card
Pharma Reviews: Indian pharma firms bat to fight Republican BAT
Under the proposal, US companies would not be taxed for profits from ... Indian generic drug makers said this would hurt their profitability — but also .
Read more: Indian pharma firms bat to fight Republican BAT
Read more: Indian pharma firms bat to fight Republican BAT
Pharma Reviews: Viewing the Indian pharma sector through the biosimilar lens
The Indian pharmaceutical market which would rank amongst the top five in terms of volume is also the largest provider of generic drugs globally.
Read more: Viewing the Indian pharma sector through the biosimilar lens
Read more: Viewing the Indian pharma sector through the biosimilar lens
Friday, January 20, 2017
Pharma Reviews: US border tax: Indian pharma cos may be hit
Mumbai: Domestic pharmaceutical companies may be impacted and could see a rough road ahead in the US, if it decides to implement the proposed ...
Read more: US border tax: Indian pharma cos may be hit
Read more: US border tax: Indian pharma cos may be hit
Pharma Reviews: Despite Note Ban, India One Of The Best Emerging Market Growth Stories: Arvind Sanger
Similarly on the pharmaceutical industry, trying to talk down drug prices is a negative but one of the ways you get lower prices is to encourage more ...
Read more: Despite Note Ban, India One Of The Best Emerging Market Growth Stories: Arvind Sanger
Read more: Despite Note Ban, India One Of The Best Emerging Market Growth Stories: Arvind Sanger
Thursday, January 19, 2017
US FDA News: FDA approves Trulance for Chronic Idiopathic Constipation
The U.S. Food and Drug Administration today approved Trulance (plecanatide) for the treatment of Chronic Idiopathic Constipation (CIC) in adult patients.
Read more: FDA approves Trulance for Chronic Idiopathic Constipation
Read more: FDA approves Trulance for Chronic Idiopathic Constipation
Pharma Reviews: View: Govt should reduce over dependence on Chinese imports of pharma raw materials
Research & development is the backbones of the Indian pharma industry and therefore there is a need to provide an impetus and incentivise R&D ...
Read more: View: Govt should reduce over dependence on Chinese imports of pharma raw materials
Read more: View: Govt should reduce over dependence on Chinese imports of pharma raw materials
US FDA News: Statement from FDA Commissioner Robert Califf, M.D. announcing FDA Oncology Center of Excellence launch
Today the U.S. Food and Drug Administration is establishing the Oncology Center of Excellence (OCE) and appointing Dr. Richard Pazdur as its director. This will make oncology the first disease area to have a coordinated clinical review of drugs, biologics and devices across the agency’s three medical product centers.
Read more: Statement from FDA Commissioner Robert Califf, M.D. announcing FDA Oncology Center of Excellence launch
Read more: Statement from FDA Commissioner Robert Califf, M.D. announcing FDA Oncology Center of Excellence launch
Wednesday, January 18, 2017
Pharma Reviews: Gujarat govt signs 249 MoUs with pharma cos attracting investments worth
... Gujarat government has signed MoUs worth Rs. 15,000 crore with both Indian and international companies in the pharma sector during the recently ...
Read more: Gujarat govt signs 249 MoUs with pharma cos attracting investments worth
Read more: Gujarat govt signs 249 MoUs with pharma cos attracting investments worth
Pharma Reviews: Dilip Surana led Microlabs Limited Wins peoples heart, voted as Best Company to work for at ...
Indeed the employees continue to work as a one family & one team making Microlabs as India's most respected pharma company with a formidable ...
Read more: Dilip Surana led Microlabs Limited Wins peoples heart, voted as Best Company to work for at ...
Read more: Dilip Surana led Microlabs Limited Wins peoples heart, voted as Best Company to work for at ...
Pharma Reviews: Pharma industry grows 29% to Rs 2.04 lakh crore in 2015-16
NEW DELHI: Indian pharmaceutical industry grew by 29 per cent to Rs 2,04,627 crore in 2015-16 from Rs 1,77,734 crore in 2014-15, while it attracted ...
Read more: Pharma industry grows 29% to Rs 2.04 lakh crore in 2015-16
Read more: Pharma industry grows 29% to Rs 2.04 lakh crore in 2015-16
Pharma Reviews: IT, pharma companies dominate business travel spending in India in 2015
Information technology and pharmaceutical companies accounted for about 60 per cent of business travel spend in India in 2015 up from about 52 per ...
Read more: IT, pharma companies dominate business travel spending in India in 2015
Read more: IT, pharma companies dominate business travel spending in India in 2015
US FDA News: Statement from FDA Commissioner Robert Califf, M.D. announcing new draft guidances on medical product communications
We recognize that there is a high level of interest regarding FDA’s views on communications about medical products. We are committed to an ongoing dialogue with industry and other stakeholders, and, when needed, providing guidance to clarify the agency’s thinking on these issues. Today, the FDA released two separate draft guidances that will each help provide clarity for medical product companies, as well as other interested parties, on FDA’s current thinking and recommendations for a few different types of communications about medical products.
Read more: Statement from FDA Commissioner Robert Califf, M.D. announcing new draft guidances on medical product communications
Read more: Statement from FDA Commissioner Robert Califf, M.D. announcing new draft guidances on medical product communications
US FDA News: FDA and EPA issue final fish consumption advice
Today, the U.S. Food and Drug Administration and the U.S. Environmental Protection Agency issued final advice regarding fish consumption. This advice is geared toward helping women who are pregnant or may become pregnant – as well as breastfeeding mothers and parents of young children – make informed choices when it comes to fish that are healthy and safe to eat. (This advice refers to fish and shellfish collectively as “fish.”)
Read more: FDA and EPA issue final fish consumption advice
Read more: FDA and EPA issue final fish consumption advice
Pharma Reviews: Daiichi Sankyo stumps industry with move to pull the plug on Indian Research and development arm
On January 10th, in a 100 word press release, Japanese pharma major Daiichi Sankyo announced that the company had decided to "to close its ...
Read more: Daiichi Sankyo stumps industry with move to pull the plug on Indian Research and development arm
Read more: Daiichi Sankyo stumps industry with move to pull the plug on Indian Research and development arm
Pharma Reviews: Meet the top 3 among 84 billionaires who own over half of India's wealth
The three businessmen are among the 84 richest Indian billionaires, ... Sun Pharmaceutical became India's largest and world's fifth largest drug firm ...
Read more: Meet the top 3 among 84 billionaires who own over half of India's wealth
Read more: Meet the top 3 among 84 billionaires who own over half of India's wealth
Pharma Reviews: Expect realty sector to rebound in 3-6 months: Morgan Stanley
On the pharmaceutical industry, Baisiwala said that he is constructive on the sector as he expects Indian companies to continue to win market share in ...
Read more: Expect realty sector to rebound in 3-6 months: Morgan Stanley
Read more: Expect realty sector to rebound in 3-6 months: Morgan Stanley
Tuesday, January 17, 2017
Pharma Reviews: Changes in US put Indian pharma's R&D to test
Indian pharmaceutical companies were dogged by concerns over quality issues, poor regulatory compliance and price fixing in 2016. But even as they ...
Read more: Changes in US put Indian pharma's R&D to test
Read more: Changes in US put Indian pharma's R&D to test
Pharma Reviews: Indian American on Trump probables list for USFDA chief
The choice is interesting given the bitter sweet relationship that the pharmaceutical industry in the US and India have with the administration.
Read more: Indian American on Trump probables list for USFDA chief
Read more: Indian American on Trump probables list for USFDA chief
US FDA News: ED-3490TK Video Duodenoscope by Pentax: FDA Safety Communication - UPDATE - Follow Pentax Validated Reprocessing Instructions
Updated recommendations to help prevent the spread of infection associated with the use of these devices.
Read more: ED-3490TK Video Duodenoscope by Pentax: FDA Safety Communication - UPDATE - Follow Pentax Validated Reprocessing Instructions
Read more: ED-3490TK Video Duodenoscope by Pentax: FDA Safety Communication - UPDATE - Follow Pentax Validated Reprocessing Instructions
Pharma Reviews: Pharma sector expects a sweet pill from budget 2017
The Indian pharma industry is a very dynamic sector and has witnessed tremendous growth as well as challenges over the last few years.
Read more: Pharma sector expects a sweet pill from budget 2017
Read more: Pharma sector expects a sweet pill from budget 2017
Monday, January 16, 2017
Pharma Reviews: Pharmaceutical - Results Preview - Mixed Performance in the US Biz; Domestic Biz to See ...
We expect 3QFY17E will be a mixed quarter for the Indian pharmaceutical companies with some of them are expected to deliver healthy sales growth ...
Read more: Pharmaceutical - Results Preview - Mixed Performance in the US Biz; Domestic Biz to See ...
Read more: Pharmaceutical - Results Preview - Mixed Performance in the US Biz; Domestic Biz to See ...
Pharma Reviews: Indian-American Balaji S Srinivasan under consideration to lead Federal Drug Administration
Indian-American Balaji S Srinivasan, a successful Silicon Valley-based ... (FDA), the all-important federal agency for drug and pharma industry.
Read more: Indian-American Balaji S Srinivasan under consideration to lead Federal Drug Administration
Read more: Indian-American Balaji S Srinivasan under consideration to lead Federal Drug Administration
Sunday, January 15, 2017
Pharma Reviews: GlaxoSmithKline Pharmaceuticals: Recovery ahead
With a nearly 4 per cent share, the company is among the major players in the India pharma market — seven of the company's brands, including ...
Read more: GlaxoSmithKline Pharmaceuticals: Recovery ahead
Read more: GlaxoSmithKline Pharmaceuticals: Recovery ahead
Pharma Reviews: India Markets Weekahead - Be cautious of a big rally before budget
He attacked the pharmaceutical industry for high drug prices and for manufacturing overseas, indicating a major shift in focus. He said he would repeal ...
Read more: India Markets Weekahead - Be cautious of a big rally before budget
Read more: India Markets Weekahead - Be cautious of a big rally before budget
Saturday, January 14, 2017
US FDA News: Lifepak 1000 Defibrillators by Physio-Control: Voluntary Field Action - Immediately Remove and Reinstall Battery
Device has shut down unexpectedly during patient treatment, which may expose patients to the risk of serious harm or death. Posted 01/14/2017
Read more: Lifepak 1000 Defibrillators by Physio-Control: Voluntary Field Action - Immediately Remove and Reinstall Battery
Read more: Lifepak 1000 Defibrillators by Physio-Control: Voluntary Field Action - Immediately Remove and Reinstall Battery
Pharma Reviews: Q3 results: Five trends to watch out from Indian drugmakers
As Indian drug makers brace up to report their third quarter earnings in the days ... and Aurobindo are the companies to watch out for with half of their ...
Read more: Q3 results: Five trends to watch out from Indian drugmakers
Read more: Q3 results: Five trends to watch out from Indian drugmakers
Friday, January 13, 2017
Pharma Reviews: Donald Trump to take office on January 20; 5 factors to watch for Indian markets
Here's is Trump presidency's likely impact on Indian industries: ... We feel IT and Pharma would be affected adversely due to his protectionist policies.
Read more: Donald Trump to take office on January 20; 5 factors to watch for Indian markets
Read more: Donald Trump to take office on January 20; 5 factors to watch for Indian markets
Pharma Reviews: Pricing pressure to continue in US for Indian generics
Kiran Mazumdar Shaw, CMD, Biocon told TOI: “The Indian generic pharma industry has been addressing the need for affordable pharmaceuticals of ...
Read more: Pricing pressure to continue in US for Indian generics
Read more: Pricing pressure to continue in US for Indian generics
US FDA News: Duodenoscopes by Fujifilm Medical Systems: Safety Communication - Certain Older Models Removed From Clinical Use
Fuji removing legacy 250/450 duodenoscope models from clinical use, replacing with with the ED-530XT model.
Read more: Duodenoscopes by Fujifilm Medical Systems: Safety Communication - Certain Older Models Removed From Clinical Use
Read more: Duodenoscopes by Fujifilm Medical Systems: Safety Communication - Certain Older Models Removed From Clinical Use
Pharma Reviews: Enter characters of the above image
Pharma major, Lupin, has launched Morphine Sulfate ER Tablets of 15 mg, 30 mg, 60 mg, ... It is the fourth largest pharmaceutical company in India.
Read more: Enter characters of the above image
Read more: Enter characters of the above image
Pharma Reviews: Stock to watch out for today: Sun Pharma
Pharma sector could well be the sector to watch out for in 2017. Sun Pharma's performance will be keenly watched as it is one of the largest Indian ...
Read more: Stock to watch out for today: Sun Pharma
Read more: Stock to watch out for today: Sun Pharma
Thursday, January 12, 2017
Pharma Reviews: Vibrant Gujarat Summit: Life sciences key to UK-India links, says British high commissioner to India
“In Britain, there are 5,500 companies in the life sciences sector generating 60 billion pounds each year. Gujarat's role in the Indian pharma industry is ...
Read more: Vibrant Gujarat Summit: Life sciences key to UK-India links, says British high commissioner to India
Read more: Vibrant Gujarat Summit: Life sciences key to UK-India links, says British high commissioner to India
Pharma Reviews: Shot in arm for pharma, medical devices
Ahmedabad: It was raining MoUs for the pharmaceutical and medical ... Saudi Arabia, which had almost no presence in the Indian pharma industry.
Read more: Shot in arm for pharma, medical devices
Read more: Shot in arm for pharma, medical devices
Pharma Reviews: Indian generic drug players unlikely to be affected by Trump attacks
The Indian pharma industry, which account for nearly 40 per cent of the generic drugs in the US, is unlikely to come under pressure after US ...
Read more: Indian generic drug players unlikely to be affected by Trump attacks
Read more: Indian generic drug players unlikely to be affected by Trump attacks
Pharma Reviews: Donald Trump's words spook Indian pharma stocks
MUMBAI: United States president-elect Donald Trump's bashing of the pharmaceuticals industry has pushed shares of Indian drug makers down, as a ...
Read more: Donald Trump's words spook Indian pharma stocks
Read more: Donald Trump's words spook Indian pharma stocks
Pharma Reviews: Pricing pressure to continue in US for Indian generics
MUMBAI: Indian companies will need to buckle up to compete in a fiercely-competitive, but most lucrative market in the world, US, in the wake of a ...
Read more: Pricing pressure to continue in US for Indian generics
Read more: Pricing pressure to continue in US for Indian generics
Pharma Reviews: Drug firms cautious as Trump raises pricing, off-shoring bogey
But the lobby-ridden drug industry was shaken out of its seeming ... The US is a magnet for Indian drug companies, being the largest market for ...
Read more: Drug firms cautious as Trump raises pricing, off-shoring bogey
Read more: Drug firms cautious as Trump raises pricing, off-shoring bogey
Pharma Reviews: Trump's attack on pharma industry won't harm Indian generic drug makers: analysts
On an average, Indian companies are witnessing 8-9% price erosion in generics in the US, which is expected to continue in the next few years.
Read more: Trump's attack on pharma industry won't harm Indian generic drug makers: analysts
Read more: Trump's attack on pharma industry won't harm Indian generic drug makers: analysts
Pharma Reviews: Indian drug companies see no threat from Trump's policies
The proposed changes in the US healthcare policies will have minimal impact on Indian companies, drug makers and sector experts said on Thursday ...
Read more: Indian drug companies see no threat from Trump's policies
Read more: Indian drug companies see no threat from Trump's policies
Pharma Reviews: Indian pharmaceutical sector may take a hit under Trump regime
The US is the largest market for Indian drug makers. In 2015, India exported $6 billion worth of drugs to the US and could feel the impact of the Trump ...
Read more: Indian pharmaceutical sector may take a hit under Trump regime
Read more: Indian pharmaceutical sector may take a hit under Trump regime
Pharma Reviews: DoP exempts pharmaceutical companies from lowering drug prices based on WPI
The Indian Pharmaceutical Alliance argued, "The DPCO 2013 mandates reduction of prices only with reference to the Ceiling Price and not the MRPs.
Read more: DoP exempts pharmaceutical companies from lowering drug prices based on WPI
Read more: DoP exempts pharmaceutical companies from lowering drug prices based on WPI
Pharma Reviews: Muted topline Q3 growth in pharma note ban impact marginal
The pharmaceutical sector is expected to report a muted revenue growth of ... "We expect Indian pharma to report revenue growth of 12 per cent and ...
Read more: Muted topline Q3 growth in pharma note ban impact marginal
Read more: Muted topline Q3 growth in pharma note ban impact marginal
US FDA News: PNC-27 Products: FDA Warning – Do Not Use For Treatment or Cure for Cancer
Consumers who use a contaminated product are at risk for serious, potentially life-threatening infections.
Read more: PNC-27 Products: FDA Warning – Do Not Use For Treatment or Cure for Cancer
Read more: PNC-27 Products: FDA Warning – Do Not Use For Treatment or Cure for Cancer
Pharma Reviews: Nifty gains for 3rd day; Trump views drag pharma, Infosys soars
Nifty gains for 3rd day; Trump views drag pharma, Infosys soars ... The market has ended on a strong note fuelled by big gains in IT and power stocks. ..... were down as major Indian pharma companies earn around 15-50 percent ...
Read more: Nifty gains for 3rd day; Trump views drag pharma, Infosys soars
Read more: Nifty gains for 3rd day; Trump views drag pharma, Infosys soars
Pharma Reviews: US to dismantle Obamacare Health Insurance scheme, Indian pharma must focus on labour cost ...
However, to remain competitive and allow the market forces to overcome President Trump's initiative, Indian pharmaceutical industry will have to ...
Read more: US to dismantle Obamacare Health Insurance scheme, Indian pharma must focus on labour cost ...
Read more: US to dismantle Obamacare Health Insurance scheme, Indian pharma must focus on labour cost ...
Pharma Reviews: COMMENT: Why Trump's rants won't make a dent in Indian IT & pharma story
COMMENT: Why Trump's rants won't make a dent in Indian IT & pharma ... In automobiles, proximity to the market is not as important as are cost and ...
Read more: COMMENT: Why Trump's rants won't make a dent in Indian IT & pharma story
Read more: COMMENT: Why Trump's rants won't make a dent in Indian IT & pharma story
Pharma Reviews: Sensex continues strong, but pharma stocks limit gains; Nifty holds above 8400
Pharmaceutical shares' extended losses continued to limit the gains in Indian markets, even as IT stocks tried to pull up the benchmark indices, as the ...
Read more: Sensex continues strong, but pharma stocks limit gains; Nifty holds above 8400
Read more: Sensex continues strong, but pharma stocks limit gains; Nifty holds above 8400
Pharma Reviews: 'Trump's pharma card to have disturbing impact on Indian cos'
In a first press meet conducted by President-elect Trump, pharmaceutical companies were targeted. Trump said that pharma companies were "getting ...
Read more: 'Trump's pharma card to have disturbing impact on Indian cos'
Read more: 'Trump's pharma card to have disturbing impact on Indian cos'
Pharma Reviews: Pharmaceutical Stocks Fall As Trump's Comments Rekindle Pricing Worries
Indian drug makers fell in early Thursday trades after U.S. President-elect Donald Trump said pharmaceutical companies were "getting away with ...
Read more: Pharmaceutical Stocks Fall As Trump's Comments Rekindle Pricing Worries
Read more: Pharmaceutical Stocks Fall As Trump's Comments Rekindle Pricing Worries
Pharma Reviews: Pharma Q3: FDA inspection, US pricing market key
Pharmaceutical companies in India are expected to post muted results for the third quarter ended December 31, 2016. Piyush Nahar and Anurag ...
Read more: Pharma Q3: FDA inspection, US pricing market key
Read more: Pharma Q3: FDA inspection, US pricing market key
Pharma Reviews: No scope of US intervention in Indian pharma cos: Wockhardt
Wockhardt chief Habil Khorakiwala says that Indian generic company as a whole is a competitive industry in US and therefore there is no scope for ...
Read more: No scope of US intervention in Indian pharma cos: Wockhardt
Read more: No scope of US intervention in Indian pharma cos: Wockhardt
Pharma Reviews: Biocon sustains Trump tamper; up more than 2%
Majority of the Indian Pharma companies which have operations in the US markets are trading down, however, Biocon was the only stock in the ...
Read more: Biocon sustains Trump tamper; up more than 2%
Read more: Biocon sustains Trump tamper; up more than 2%
Wednesday, January 11, 2017
Pharma Reviews: Indian exports to be hit? Prioritising job creation, Trump targets pharmas
"Our drug industry has been disastrous. They're leaving left and right. They supply our drugs, but they don't make them here, to a large extent." India ...
Read more: Indian exports to be hit? Prioritising job creation, Trump targets pharmas
Read more: Indian exports to be hit? Prioritising job creation, Trump targets pharmas
Pharma Reviews: Pharma falls on Trump's comments, analysts say impact unlikely
Major Indian pharma companies earn around 15-50 percent revenue from the US ... Shares of pharma companies were under pressure following US ...
Read more: Pharma falls on Trump's comments, analysts say impact unlikely
Read more: Pharma falls on Trump's comments, analysts say impact unlikely
Pharma Reviews: Pharma stocks fall on Donald Trump's targeted attack
BSE Healthcare Index fell 1.1%, while India's benchmark Sensex Index ... Mumbai: Shares of pharmaceuticals companies on Thursday fell after US ...
Read more: Pharma stocks fall on Donald Trump's targeted attack
Read more: Pharma stocks fall on Donald Trump's targeted attack
Pharma Reviews: Pharma Stocks Hit After Trump's 'Getting Away With Murder' Comment
The US is a big export market for many Indian drug companies. Dr Reddy's Laboratories, Sun Pharmaceutical Industries and Lupin were the most hit, ...
Read more: Pharma Stocks Hit After Trump's 'Getting Away With Murder' Comment
Read more: Pharma Stocks Hit After Trump's 'Getting Away With Murder' Comment
Pharma Reviews: Sensex higher, Midcap corrects; pharma, FMCG, metals stocks slip
“I don't think these are going to be big issues; if Indian pharma companies are supplying these products to the US markets and if there are no US ...
Read more: Sensex higher, Midcap corrects; pharma, FMCG, metals stocks slip
Read more: Sensex higher, Midcap corrects; pharma, FMCG, metals stocks slip
Pharma Reviews: India markets open marginally up; Pharma stocks hit on Donald Trump's presser; Nifty trading ...
Benchmark Indian indices opened marginally higher with most Pharmaceutical stocks taking a major beating after the US President-elect Donald ...
Read more: India markets open marginally up; Pharma stocks hit on Donald Trump's presser; Nifty trading ...
Read more: India markets open marginally up; Pharma stocks hit on Donald Trump's presser; Nifty trading ...
Pharma Reviews: Gujarat govt to sign 250 MoUs related to pharma sector at Vibrant Gujarat Global Summit-2017
These MoUs come at a time when Gujarat has become a favoured pharmaceutical hub accounting for nearly 40 per cent of India's pharma production ...
Read more: Gujarat govt to sign 250 MoUs related to pharma sector at Vibrant Gujarat Global Summit-2017
Read more: Gujarat govt to sign 250 MoUs related to pharma sector at Vibrant Gujarat Global Summit-2017
Pharma Reviews: I don't see Trump's views affecting Indian drug cos: Biocon CMD
Following US president-elect Donald Trump's explosive speech last night where he lambasted the domestic pharma companies for outsourcing work, ...
Read more: I don't see Trump's views affecting Indian drug cos: Biocon CMD
Read more: I don't see Trump's views affecting Indian drug cos: Biocon CMD
Pharma Reviews: IT, pharma in focus after Trump's tough talk on pricing
US president-elect claimed pharmaceutical companies were “getting away with ... shortly after price approvals, which could impact pharma companies. ... of Obamacare would impact the Indian pharma sector in one way or the other.
Read more: IT, pharma in focus after Trump's tough talk on pricing
Read more: IT, pharma in focus after Trump's tough talk on pricing
Pharma Reviews: Opening bell: Asian markets open mixed; pharma stocks, TCS in focus
US president-elect Donald Trump has attacked the pharmaceutical industry for high drug prices and ... US is the largest market for Indian drug firms.
Read more: Opening bell: Asian markets open mixed; pharma stocks, TCS in focus
Read more: Opening bell: Asian markets open mixed; pharma stocks, TCS in focus
Pharma Reviews: Life sciences key to UK-India links
"In Britain, there are 5,500 companies in the life sciences sector generating 60 billion pounds each year. Gujarat's role in the Indian pharma industry is ...
Read more: Life sciences key to UK-India links
Read more: Life sciences key to UK-India links
Pharma Reviews: Big Trump card could hit Indian IT, pharma! Five takeaways from presser
NEW DELHI: The first presser of US President-elect Donald Trump could put IT and pharma stocks in a tight spot when the domestic market opens for ...
Read more: Big Trump card could hit Indian IT, pharma! Five takeaways from presser
Read more: Big Trump card could hit Indian IT, pharma! Five takeaways from presser
US FDA News: Medrad Intego PET Infusion System Source Administration Sets by Bayer: Recall - Particulates Generated in Vial
The particulate matter could enter into the patient and cause serious adverse health consequences including infection, damage of tissue, and death.
Read more: Medrad Intego PET Infusion System Source Administration Sets by Bayer: Recall - Particulates Generated in Vial
Read more: Medrad Intego PET Infusion System Source Administration Sets by Bayer: Recall - Particulates Generated in Vial
US FDA News: Implantable Infusion Pumps in the Magnetic Resonance (MR) Environment: FDA Safety Communication - Important Safety Precautions
Reports of serious adverse events, including patient injury & death, describing medication dosing inaccuracies and other mechanical problems with pumps after an MRI exam.
Read more: Implantable Infusion Pumps in the Magnetic Resonance (MR) Environment: FDA Safety Communication - Important Safety Precautions
Read more: Implantable Infusion Pumps in the Magnetic Resonance (MR) Environment: FDA Safety Communication - Important Safety Precautions
Pharma Reviews: Sunset for public sector drug makers
The life story of these companies is intricately linked to the birth and growth of India's pharmaceutical industry and they have played a key role in ...
Read more: Sunset for public sector drug makers
Read more: Sunset for public sector drug makers
Pharma Reviews: Driven by anti-diabetic & cardiac drug sales, Indian pharma grew by 7.2%
New Delhi: Sales in the Indian pharmaceutical market grew 7.2 per cent on year to Rs 91.31 billion in December on account of strong growth in sales ...
Read more: Driven by anti-diabetic & cardiac drug sales, Indian pharma grew by 7.2%
Read more: Driven by anti-diabetic & cardiac drug sales, Indian pharma grew by 7.2%
Pharma Reviews: LSCPL, Convalgroup to launch Conval Academy for computerized system validation course
If students are trained in CSV upfront, then apart from their own career prospects, Indian pharmaceutical industry will be benefited with their special ...
Read more: LSCPL, Convalgroup to launch Conval Academy for computerized system validation course
Read more: LSCPL, Convalgroup to launch Conval Academy for computerized system validation course
Pharma Reviews: SES highlights long receivables period for Indian pharma companies
The report, which compared receivables turnover ratios of 24 pharmaceutical companies for last three fiscal years, showed that Glenmark's ...
Read more: SES highlights long receivables period for Indian pharma companies
Read more: SES highlights long receivables period for Indian pharma companies
Pharma Reviews: ChrysCapital to sell stake in Intas Pharma
Intas is among the top 10 Indian drug firms and the largest privately held pharmaceutical company in India, with annual turnover in excess of $1 billion, ...
Read more: ChrysCapital to sell stake in Intas Pharma
Read more: ChrysCapital to sell stake in Intas Pharma
Pharma Reviews: India has the biggest potential for Geistlich Pharma: Paul Note
Ours is a family-based company headquartered in Lausanne, Switzerland. ... Creation of Geistlich Pharma India was needed to serve the dental ...
Read more: India has the biggest potential for Geistlich Pharma: Paul Note
Read more: India has the biggest potential for Geistlich Pharma: Paul Note
Pharma Reviews: Revised National IPR Policy India- From Industry And Public Development Perspective
This has given a great reprise to the Indian generic pharma industry, otherwise in case patents are granted to International firms like Tykerb which ...
Read more: Revised National IPR Policy India- From Industry And Public Development Perspective
Read more: Revised National IPR Policy India- From Industry And Public Development Perspective
Pharma Reviews: Intas Pharmaceuticals Completes Deal to Acquire Actavis
Intas Pharmaceuticals Completes Deal to Acquire Actavis UK & Ireland Generics Businesses From Teva AHMEDABAD, India, January 10, ...
Read more: Intas Pharmaceuticals Completes Deal to Acquire Actavis
Read more: Intas Pharmaceuticals Completes Deal to Acquire Actavis
Pharma Reviews: Indian pharma market grew by 7.2% to
Indian pharma market achieved lower growth of 7.2 per cent during the month of December 2016 as compared to 11.9 per cent in the corresponding ...
Read more: Indian pharma market grew by 7.2% to
Read more: Indian pharma market grew by 7.2% to
Monday, January 9, 2017
US FDA News: Implantable Cardiac Devices and Merlin@home Transmitter by St. Jude Medical: FDA Safety Communication - Cybersecurity Vulnerabilities Identified
These vulnerabilities, if exploited, could allow an unauthorized user to remotely access a patient's RF-enabled implanted cardiac device by altering the Merlin@home Transmitter.
Read more: Implantable Cardiac Devices and Merlin@home Transmitter by St. Jude Medical: FDA Safety Communication - Cybersecurity Vulnerabilities Identified
Read more: Implantable Cardiac Devices and Merlin@home Transmitter by St. Jude Medical: FDA Safety Communication - Cybersecurity Vulnerabilities Identified
Pharma Jobs: Business Development Manager / BDM / Sales Manager /Dairy farming(Dairy Industry/veterinary)
Company: Deltech Health Care Private Limited
Experience: 5 to 10
location: Chandigarh, Ludhiana
Ref: 19942192
Summary: Hiring Business Development Manager/BDM/Sales Manager/Dairy farming(Dairy Industry/veterinary)with relevant experience of the cattle health sector, with a stress on helping the farmer to control mastitis in ....
Read more: Business Development Manager / BDM / Sales Manager /Dairy farming(Dairy Industry/veterinary)
Experience: 5 to 10
location: Chandigarh, Ludhiana
Ref: 19942192
Summary: Hiring Business Development Manager/BDM/Sales Manager/Dairy farming(Dairy Industry/veterinary)with relevant experience of the cattle health sector, with a stress on helping the farmer to control mastitis in ....
Read more: Business Development Manager / BDM / Sales Manager /Dairy farming(Dairy Industry/veterinary)
Pharma Reviews: Indian drug market growth moderates to 7.2% in December
The domestic drug market grew at 7.2 percent in December, compared to 15.5 percent growth in November due to slowdown in uptake of chronic ...
Read more: Indian drug market growth moderates to 7.2% in December
Read more: Indian drug market growth moderates to 7.2% in December
Pharma Reviews: Ajanta Pharma receives US FDA nod for Duloxetine capsules
Ajanta Pharma receives US FDA nod for Duloxetine capsules ... Mumbai headquartered specialty pharmaceutical company Ajanta Pharma in an ... news concerning the Indian pharma industry and other regulatory concerns.
Read more: Ajanta Pharma receives US FDA nod for Duloxetine capsules
Read more: Ajanta Pharma receives US FDA nod for Duloxetine capsules
Pharma Reviews: Pharma companies want you to pay more for 'risky' bioresorbable stents
Bioresorbable stents were introduced into the Indian market and in Europe by Abbott in 2012. However, it did not receive US FDA approval till March ...
Read more: Pharma companies want you to pay more for 'risky' bioresorbable stents
Read more: Pharma companies want you to pay more for 'risky' bioresorbable stents
Sunday, January 8, 2017
Pharma Reviews: Health ministry to mandate upgradation of Schedule M units to WHO-GMP level
Global GMP violations have hurt India's image as an inexpensive and ... Also, Indian pharmaceutical companies have the largest share of DMFs and ...
Read more: Health ministry to mandate upgradation of Schedule M units to WHO-GMP level
Read more: Health ministry to mandate upgradation of Schedule M units to WHO-GMP level
Pharma Reviews: Glenmark Pharmaceuticals: Making a mark - Buy
The year 2016 was a docile one for Indian pharma companies. Regulatory tightening by the US drug regulator, coupled with price cuts in India, did not ...
Read more: Glenmark Pharmaceuticals: Making a mark - Buy
Read more: Glenmark Pharmaceuticals: Making a mark - Buy
Saturday, January 7, 2017
Pharma Reviews: Aurobindo Pharma to buy Portugal's Generis Farmaceutica for $142 mn
Aurobindo Pharma will acquire Generis through its wholly-owned ... Indian pharmaceutical companies have been stitching strategic deals in the past ...
Read more: Aurobindo Pharma to buy Portugal's Generis Farmaceutica for $142 mn
Read more: Aurobindo Pharma to buy Portugal's Generis Farmaceutica for $142 mn
Friday, January 6, 2017
Pharma Reviews: How top Indian drug makers like Sun Pharma, Glenmark are building a brands business in the US
“Innovative brands as opposed to supplying generics to distributors is a significant shift. Indian companies are at a stage of maturity where building a ...
Read more: How top Indian drug makers like Sun Pharma, Glenmark are building a brands business in the US
Read more: How top Indian drug makers like Sun Pharma, Glenmark are building a brands business in the US
Pharma Reviews: ACG expanding its footprint across the globe by focusing on quality products
ACG ACPL is one of the largest producers among pharmaceutical grade ... India's leadership and competitive advantage in global pharmaceutical ...
Read more: ACG expanding its footprint across the globe by focusing on quality products
Read more: ACG expanding its footprint across the globe by focusing on quality products
Thursday, January 5, 2017
Pharma Jobs: Urgent Requirements for Managers in health care in Canada
Company: Kanvisa Overseas Consultants Private Limited
Qualification: Any graduate
Experience: 1 to 10
location: Canada
Ref: 19881544
Summary: This unit group includes managers who plan, organize, direct, control and evaluate the delivery of health care services, such as diagnosis and treatment, nursing and therapy,....
Read more: Urgent Requirements for Managers in health care in Canada
Qualification: Any graduate
Experience: 1 to 10
location: Canada
Ref: 19881544
Summary: This unit group includes managers who plan, organize, direct, control and evaluate the delivery of health care services, such as diagnosis and treatment, nursing and therapy,....
Read more: Urgent Requirements for Managers in health care in Canada
Pharma Jobs: Urgent openings for Physicists and astronomers in Canada.
Company: Kanvisa Overseas Consultants Private Limited
Qualification: Other
Experience: 1 to 10
location: Canada
Ref: 19886030
Summary: Physicists conduct theoretical applied research to extend knowledge of natural phenomena to develop new processes and devices in fields like electronics, communications, power....
Read more: Urgent openings for Physicists and astronomers in Canada.
Qualification: Other
Experience: 1 to 10
location: Canada
Ref: 19886030
Summary: Physicists conduct theoretical applied research to extend knowledge of natural phenomena to develop new processes and devices in fields like electronics, communications, power....
Read more: Urgent openings for Physicists and astronomers in Canada.
Pharma Jobs: Urgent opening for Chemists in Canada.
Company: Kanvisa Overseas Consultants Private Limited
Qualification: Other
Experience: 1 to 10
location: Canada
Ref: 19886133
Summary: Chemists conduct research and analysis in support of industrial operations, product and process development, quality control, environmental control, medical diagnosis and treatment,....
Read more: Urgent opening for Chemists in Canada.
Qualification: Other
Experience: 1 to 10
location: Canada
Ref: 19886133
Summary: Chemists conduct research and analysis in support of industrial operations, product and process development, quality control, environmental control, medical diagnosis and treatment,....
Read more: Urgent opening for Chemists in Canada.
Pharma Jobs: Urgent requirement for Chemical technologists and technicians in canada.
Company: Kanvisa Overseas Consultants Private Limited
Qualification: Other
Experience: 1 to 10
location: Canada
Ref: 19886557
Summary: Chemical technologists and technicians provide technical support and services /may work independently in chemical engineering, chemical and biochemical research and analysis, industrial ....
Read more: Urgent requirement for Chemical technologists and technicians in canada.
Qualification: Other
Experience: 1 to 10
location: Canada
Ref: 19886557
Summary: Chemical technologists and technicians provide technical support and services /may work independently in chemical engineering, chemical and biochemical research and analysis, industrial ....
Read more: Urgent requirement for Chemical technologists and technicians in canada.
Pharma Jobs: Urgent requirement for Chemical technologists and technicians in canada
Company: Kanvisa Overseas Consultants Private Limited
Qualification: B.Pharm, Other
Experience: 1 to 10
location: Canada
Ref: 19888543
Summary: Chemical technologists and technicians provide technical support and services/may work independently in chemical engineering, chemical and biochemical research and....
Read more: Urgent requirement for Chemical technologists and technicians in canada
Qualification: B.Pharm, Other
Experience: 1 to 10
location: Canada
Ref: 19888543
Summary: Chemical technologists and technicians provide technical support and services/may work independently in chemical engineering, chemical and biochemical research and....
Read more: Urgent requirement for Chemical technologists and technicians in canada
Pharma Jobs: Urgent requirement for Biological technologists and technicians in canada.
Company: Kanvisa Overseas Consultants Private Limited
Qualification: B.Pharm, Other
Experience: 1 to 10
location: Canada
Ref: 19888826
Summary: Biological technologists and technicians provide technical support and services to scientists, engineers and other professionals working in fields.
Read more: Urgent requirement for Biological technologists and technicians in canada.
Qualification: B.Pharm, Other
Experience: 1 to 10
location: Canada
Ref: 19888826
Summary: Biological technologists and technicians provide technical support and services to scientists, engineers and other professionals working in fields.
Read more: Urgent requirement for Biological technologists and technicians in canada.
Pharma Jobs: Urgent openings for Chemical engineers in Canada.
Company: Kanvisa Overseas Consultants Private Limited
Qualification: B.E/B.Tech, M.E/M.Tech/MS
Experience: 1 to 10
location: Canada
Ref: 19888976
Summary: Chemical engineers design, develop chemical processes, equipment, the operation and maintenance of industrial chemical, plastics, pharmaceutical, resource,....
Read more: Urgent openings for Chemical engineers in Canada.
Qualification: B.E/B.Tech, M.E/M.Tech/MS
Experience: 1 to 10
location: Canada
Ref: 19888976
Summary: Chemical engineers design, develop chemical processes, equipment, the operation and maintenance of industrial chemical, plastics, pharmaceutical, resource,....
Read more: Urgent openings for Chemical engineers in Canada.
Pharma Jobs: Looking for Inspectors in public, environmental health, occupational health, safety in canada
Company: Kanvisa Overseas Consultants Private Limited
Qualification: Any graduate, Diploma, Other
Experience: 1 to 10
location: Canada
Ref: 19890980
Summary: Inspectors in this unit group evaluate and monitor health and safety hazards and develop strategies to control risks in the workplace.
Read more: Looking for Inspectors in public, environmental health, occupational health, safety in canada
Qualification: Any graduate, Diploma, Other
Experience: 1 to 10
location: Canada
Ref: 19890980
Summary: Inspectors in this unit group evaluate and monitor health and safety hazards and develop strategies to control risks in the workplace.
Read more: Looking for Inspectors in public, environmental health, occupational health, safety in canada
Pharma Jobs: Urgent openings for Specialist physicians in Canada.
Company: Kanvisa Overseas Consultants Private Limited
Qualification: B.Sc, Other
Experience: 1 to 10
location: Canada
Ref: 19891381
Summary: This unit group includes specialist physicians in clinical medicine, in laboratory medicine and surgery. Specialists in clinical medicine diagnose/treat diseases and....
Read more: Urgent openings for Specialist physicians in Canada.
Qualification: B.Sc, Other
Experience: 1 to 10
location: Canada
Ref: 19891381
Summary: This unit group includes specialist physicians in clinical medicine, in laboratory medicine and surgery. Specialists in clinical medicine diagnose/treat diseases and....
Read more: Urgent openings for Specialist physicians in Canada.
Pharma Jobs: QC Chemist
Company: Vitasta Consulting Private Limited
Qualification: Other
Experience: 2 to 3
location: Pune
Ref: 19898263
Summary: Job Description To carry outsampling of RM under the guidance To ensure that material testing ,inspection & quality testing of raw materials are done in a timely & accurate manner To insure proper....
Read more: QC Chemist
Qualification: Other
Experience: 2 to 3
location: Pune
Ref: 19898263
Summary: Job Description To carry outsampling of RM under the guidance To ensure that material testing ,inspection & quality testing of raw materials are done in a timely & accurate manner To insure proper....
Read more: QC Chemist
Pharma Reviews: 'Post demonetisation, money with banks should be used for infra projects'
If the Indian industry has to become globally competitive, I think the interest ... Indian pharma companies are increasingly falling foul of the US FDA.
Read more: 'Post demonetisation, money with banks should be used for infra projects'
Read more: 'Post demonetisation, money with banks should be used for infra projects'
Pharma Reviews: Sale of India's First Pharma Company approved by the Union Cabinet
The Union Cabinet chaired by the Prime Minister Narendra Modi has recently approved strategic sale of India's first pharmaceutical company, Bengal ...
Read more: Sale of India's First Pharma Company approved by the Union Cabinet
Read more: Sale of India's First Pharma Company approved by the Union Cabinet
Pharma Reviews: Why there is a problem with pharma companies sponsoring medical conferences in India
This practice of Indian medical conferences being sponsored by pharmaceutical companies has prompted questions from activists. Jan Swasthya ...
Read more: Why there is a problem with pharma companies sponsoring medical conferences in India
Read more: Why there is a problem with pharma companies sponsoring medical conferences in India
Tuesday, January 3, 2017
Pharma Reviews: Indian companies grab 34% of total US FDA approvals during 2016
Indian pharmaceutical companies have registered strong presence in highly regulated markets like US and Europe with rising investment in research ...
Read more: Indian companies grab 34% of total US FDA approvals during 2016
Read more: Indian companies grab 34% of total US FDA approvals during 2016
Pharma Reviews: Outlook 2017: Five trends to watch out for in healthcare space
Drugmaker Laurus Labs also joined a strong list of pharmaceutical ... second-biggest overseas acquisition by an Indian pharmaceutical company ever ...
Read more: Outlook 2017: Five trends to watch out for in healthcare space
Read more: Outlook 2017: Five trends to watch out for in healthcare space
Pharma Reviews: Japanese companies make cautious return to Indian pharma market
MUMBAI: After burning their fingers more than once in India with troubled acquisitions, Japanese drug makers are back in this market, this time ...
Read more: Japanese companies make cautious return to Indian pharma market
Read more: Japanese companies make cautious return to Indian pharma market
Pharma Reviews: 350 MSMEs to be set up in phase-1 of Pharma City in Telangana
While talking with KNN, Past President of Indian Pharmaceutical Association, Dr. JAS Giri said that the move by state government will certainly boost ...
Read more: 350 MSMEs to be set up in phase-1 of Pharma City in Telangana
Read more: 350 MSMEs to be set up in phase-1 of Pharma City in Telangana
Pharma Reviews: 4th Nigeria Pharma Manufacturers Expo 2017 to be held from Aug 30-Sept 1
4th Nigeria Pharma Manufacturers Expo 2017 (NPME 2017), an international exhibition on pharmaceutical industry is happening for the 4th time ...
Read more: 4th Nigeria Pharma Manufacturers Expo 2017 to be held from Aug 30-Sept 1
Read more: 4th Nigeria Pharma Manufacturers Expo 2017 to be held from Aug 30-Sept 1
Monday, January 2, 2017
Pharma Jobs: Urgent Requirements for Managers in health care in Canada
Company: Kanvisa Overseas Consultants Private Limited
Qualification: Any graduate
Experience: 1 to 10
location: Canada
Ref: 19881544
Summary: This unit group includes managers who plan, organize, direct, control and evaluate the delivery of health care services, such as diagnosis and treatment, nursing and therapy,....
Read more: Urgent Requirements for Managers in health care in Canada
Qualification: Any graduate
Experience: 1 to 10
location: Canada
Ref: 19881544
Summary: This unit group includes managers who plan, organize, direct, control and evaluate the delivery of health care services, such as diagnosis and treatment, nursing and therapy,....
Read more: Urgent Requirements for Managers in health care in Canada
Pharma Jobs: Urgent openings for Physicists and astronomers in Canada.
Company: Kanvisa Overseas Consultants Private Limited
Qualification: Other
Experience: 1 to 10
location: Canada
Ref: 19886030
Summary: Physicists conduct theoretical applied research to extend knowledge of natural phenomena to develop new processes and devices in fields like electronics, communications, power....
Read more: Urgent openings for Physicists and astronomers in Canada.
Qualification: Other
Experience: 1 to 10
location: Canada
Ref: 19886030
Summary: Physicists conduct theoretical applied research to extend knowledge of natural phenomena to develop new processes and devices in fields like electronics, communications, power....
Read more: Urgent openings for Physicists and astronomers in Canada.
Pharma Jobs: Urgent opening for Chemists in Canada.
Company: Kanvisa Overseas Consultants Private Limited
Qualification: Other
Experience: 1 to 10
location: Canada
Ref: 19886133
Summary: Chemists conduct research and analysis in support of industrial operations, product and process development, quality control, environmental control, medical diagnosis and treatment,....
Read more: Urgent opening for Chemists in Canada.
Qualification: Other
Experience: 1 to 10
location: Canada
Ref: 19886133
Summary: Chemists conduct research and analysis in support of industrial operations, product and process development, quality control, environmental control, medical diagnosis and treatment,....
Read more: Urgent opening for Chemists in Canada.
Pharma Jobs: Urgent requirement for Chemical technologists and technicians in canada.
Company: Kanvisa Overseas Consultants Private Limited
Qualification: Other
Experience: 1 to 10
location: Canada
Ref: 19886557
Summary: Chemical technologists and technicians provide technical support and services /may work independently in chemical engineering, chemical and biochemical research and analysis, industrial ....
Read more: Urgent requirement for Chemical technologists and technicians in canada.
Qualification: Other
Experience: 1 to 10
location: Canada
Ref: 19886557
Summary: Chemical technologists and technicians provide technical support and services /may work independently in chemical engineering, chemical and biochemical research and analysis, industrial ....
Read more: Urgent requirement for Chemical technologists and technicians in canada.
Pharma Jobs: Looking for Inspectors in public, environmental health, occupational health, safety in canada
Company: Kanvisa Overseas Consultants Private Limited
Qualification: Any graduate, Diploma, Other
Experience: 1 to 10
location: Canada
Ref: 19890980
Summary: Inspectors in this unit group evaluate and monitor health and safety hazards and develop strategies to control risks in the workplace.
Read more: Looking for Inspectors in public, environmental health, occupational health, safety in canada
Qualification: Any graduate, Diploma, Other
Experience: 1 to 10
location: Canada
Ref: 19890980
Summary: Inspectors in this unit group evaluate and monitor health and safety hazards and develop strategies to control risks in the workplace.
Read more: Looking for Inspectors in public, environmental health, occupational health, safety in canada
Pharma Jobs: Eexecutive - Analytical & Formulation -Injactable
Company: ScaleneWorks People Solutions LLP
Qualification: B.E/B.Tech
Experience: 2 to 6
location: Pune
Ref: 19908062
Summary: · Responsible for Planning of daily work by maintaining GLP, cGMP’s as per company procedures · Responsible for interpretation of analytical data and communicating the same to concern groups ....
Read more: Eexecutive - Analytical & Formulation -Injactable
Qualification: B.E/B.Tech
Experience: 2 to 6
location: Pune
Ref: 19908062
Summary: · Responsible for Planning of daily work by maintaining GLP, cGMP’s as per company procedures · Responsible for interpretation of analytical data and communicating the same to concern groups ....
Read more: Eexecutive - Analytical & Formulation -Injactable
Pharma Jobs: Medical Coding For M.Pharmacy / B.Pharmacy Graduates
Company: ScaleneWorks People Solutions LLP
Experience: 0 to 5
location: Other India
Ref: 19908112
Summary: Designation-Medical Coder Trainee Eligibility… Nursing Pharmacy Biotechnology Microbiology Bio Medical Bio Chemistry Bio Informatics Biology Chemistry Botany Zoology Advanced Zoology PlantBiology Anatomy ....
Read more: Medical Coding For M.Pharmacy / B.Pharmacy Graduates
Experience: 0 to 5
location: Other India
Ref: 19908112
Summary: Designation-Medical Coder Trainee Eligibility… Nursing Pharmacy Biotechnology Microbiology Bio Medical Bio Chemistry Bio Informatics Biology Chemistry Botany Zoology Advanced Zoology PlantBiology Anatomy ....
Read more: Medical Coding For M.Pharmacy / B.Pharmacy Graduates
Pharma Jobs: clinical Research Associate
Company: ScaleneWorks People Solutions LLP
Experience: 2 to 3
location: Ahmedabad
Ref: 19910603
Summary:
Read more: clinical Research Associate
Experience: 2 to 3
location: Ahmedabad
Ref: 19910603
Summary:
Read more: clinical Research Associate
Pharma Jobs: Scientific Manager Protein Formulation
Company: ScaleneWorks People Solutions LLP
Experience: 2 to 6
location: Bengaluru / Bangalore
Ref: 19910845
Summary: Biocon is an integrated biotechnology enterprise focused on the development of biopharmaceuticals With successful initiatives in drug discovery and development bioprocessing manufacturing and global marketing....
Read more: Scientific Manager Protein Formulation
Experience: 2 to 6
location: Bengaluru / Bangalore
Ref: 19910845
Summary: Biocon is an integrated biotechnology enterprise focused on the development of biopharmaceuticals With successful initiatives in drug discovery and development bioprocessing manufacturing and global marketing....
Read more: Scientific Manager Protein Formulation
Pharma Jobs: Regulatory Affairs Manager
Company: ScaleneWorks People Solutions LLP
Experience: 0 to 1
location: Bhopal
Ref: 19911952
Summary: Supervising central and non-central European licensing procedures (new applicationsor variationsor renewals. Establishment and maintenance of contacts between MSD AH and EU regulatory authorities. Advising on regulatory....
Read more: Regulatory Affairs Manager
Experience: 0 to 1
location: Bhopal
Ref: 19911952
Summary: Supervising central and non-central European licensing procedures (new applicationsor variationsor renewals. Establishment and maintenance of contacts between MSD AH and EU regulatory authorities. Advising on regulatory....
Read more: Regulatory Affairs Manager
Pharma Jobs: Research Associate - Fresher - Andheri, Mumbai
Company: ScaleneWorks People Solutions LLP
Experience: 0 to 1
location: Mumbai, Navi Mumbai
Ref: 19912473
Summary: Loc : Andheri, Mumbai Exp - 0 t0 1 year Qualification : Graduate (any stream; preferably IT/Computer Science) with an IT background Gender : Male / Female Job Description : * Understanding and defining the....
Read more: Research Associate - Fresher - Andheri, Mumbai
Experience: 0 to 1
location: Mumbai, Navi Mumbai
Ref: 19912473
Summary: Loc : Andheri, Mumbai Exp - 0 t0 1 year Qualification : Graduate (any stream; preferably IT/Computer Science) with an IT background Gender : Male / Female Job Description : * Understanding and defining the....
Read more: Research Associate - Fresher - Andheri, Mumbai
Pharma Jobs: Research Associate - Education Startup
Company: ScaleneWorks People Solutions LLP
Experience: 2 to 4
location: Bengaluru / Bangalore
Ref: 19912951
Summary: Current Clientele : Premier schools of the country including: The Doon School, Lawrence School Sanawar, Sishya School Chennai, NPS Bangalore etc. They service 70 schools in 15 states. The Research Associate is....
Read more: Research Associate - Education Startup
Experience: 2 to 4
location: Bengaluru / Bangalore
Ref: 19912951
Summary: Current Clientele : Premier schools of the country including: The Doon School, Lawrence School Sanawar, Sishya School Chennai, NPS Bangalore etc. They service 70 schools in 15 states. The Research Associate is....
Read more: Research Associate - Education Startup
Pharma Jobs: Urgent opening for M.Sc / M. A Psychology Patiala District
Company: ScaleneWorks People Solutions LLP
Qualification: M.Sc
Experience: 0 to 1
location: Patiala
Ref: 19913448
Summary: Experience: Fresher Salary: 10k to 15k PM Location : Patiala (Punjab) Company : Hospital No. of opening : 4 Person should have done M.Sc / M.A psychology or any candidate with Clinical Psychology.....
Read more: Urgent opening for M.Sc / M. A Psychology Patiala District
Qualification: M.Sc
Experience: 0 to 1
location: Patiala
Ref: 19913448
Summary: Experience: Fresher Salary: 10k to 15k PM Location : Patiala (Punjab) Company : Hospital No. of opening : 4 Person should have done M.Sc / M.A psychology or any candidate with Clinical Psychology.....
Read more: Urgent opening for M.Sc / M. A Psychology Patiala District
Pharma Reviews: Outlook for pharma, education and microfinance in 2017
What can the Indian pharma companies hope to look forward to in the new year? After all, market headwinds in the form of drug pricing pressures ...
Read more: Outlook for pharma, education and microfinance in 2017
Read more: Outlook for pharma, education and microfinance in 2017
Pharma Reviews: Recipharm receives FIPB approval to acquire Kemwell's Indian operation
The second acquisition, regarding Kemwell's pharmaceutical operations in India, was conditional on governmental approvals, and was expected to ...
Read more: Recipharm receives FIPB approval to acquire Kemwell's Indian operation
Read more: Recipharm receives FIPB approval to acquire Kemwell's Indian operation
Pharma Reviews: New Year, new requirements- Cos stare at high compliance costs with new laws
“Indian pharma companies are taking regulatory risks emanating from US FDA, US Foreign Corrupt Practices Act and Indian government's Uniform ...
Read more: New Year, new requirements- Cos stare at high compliance costs with new laws
Read more: New Year, new requirements- Cos stare at high compliance costs with new laws
Sunday, January 1, 2017
Pharma Reviews: Pharma & healthcare sectors see R&D, manufacture & predictive analytics as growth drivers in 2017
Indian pharma companies will prove its mettle in R&D and manufacture in 2017. The sector's capability holds immense potential in contract research ...
Read more: Pharma & healthcare sectors see R&D, manufacture & predictive analytics as growth drivers in 2017
Read more: Pharma & healthcare sectors see R&D, manufacture & predictive analytics as growth drivers in 2017
Subscribe to:
Comments (Atom)